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Introduction
Pancreatic cancer is the eighth most commonly diag-
nosed cancer in the developed world and has one of the
worst prognoses of any malignancy with 98% succumb-
ing to their disease within 5 years. Little is known about
the etiology of the disease despite significant new
insights into the mutation signatures common to this
disease. The antioxidants, including vitamins C, E, Se,
Zn might prevent pancreatic cancer. In the current
study we have examined the levels of Cu, Fe, Zn and Se
in a moderately sized pancreatic cancer population and
compared it to a healthy age-matched population.
Material and methods
A total of 48 pancreatic cancer patients and 48 aged-
matched healthy controls were enrolled in the study
after providing informed consent. The patients with
pancreatic cancer were enrolled to the study from the
Hospital of the Ministry of Internal Affairs and Admin-
istration in Szczecin, Poland. For each pancreatic cancer
patient included in this study an unaffected individual
registered in International Hereditary Cancer Center,
Pomeranian Medical University of Szczecin, was used as
a control.
Each person enrolled in the study donated ~10 ml
EDTA blood for sufficient serum to be isolated and
examined for the elements Cu, Se, Fe and Zn.The level
of Cu, Fe, Se, and Zn, in the serum was determined by
mass spectrometry Inductively Coupled Plasma Mass
Spectrometry (Elan DRC-e, PerkinElmer).
Results
Conclusions
1. There is a very strong correlation between the
level of selenium, copper in serum and the risk of
pancreatic cancers in the Polish population.
2. The Se, Cu level in serum and especially ratio Cu/
Se may be a useful diagnostic tool of pancreatic
cancer.
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Table 1. Association between Se serum concentration
and risk of pancreatic cancer
Cancer site Quartile Selenium concentration
range (µg/l)








I vs II: p=0.013. OR = 13.000
I vs III: p=0.013. OR = 13.000
I vs IV, p< 0.0001, OR = 55.000
Table 2. Association between Cu serum concentration
and risk of pancreatic cancer
Cancer site Quartile Copper concentration
range (µg/l)








II vs I: p = 0.049, OR = 5.000
III vs I: p = 0.0114, OR = 7.000
IV vs I: p< 0.0001, OR = 161.000
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3. Further investigations are needed to determine if
Cu/Se ratio can be used in:
a. differential diagnosis of pancreatic tumor (PT),
b. identification of causative factors of PT,
c. identification of prognostic factor of PC.
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Table 4. Association between Zn serum concentration
and risk of pancreatic cancer
Cancer site Quartile Zinc concentration
range (µg/l)








I vs II: p = 0.082
I vs III: p = 0.770
I vs IV: p = 0.561
Table 3. Association between Fe serum concentration
and risk of pancreatic cancer
Cancer site Quartile Iron concentration
range (µg/l)








I vs II: p = 0.0331, OR = 4.680
I vs III p = 0.0027, OR = 8.229
I vs IV: p = 0.0654, OR = 3.927
Table 5. Ratio Cu/Se
Cancer site Quartile Cu/Se concentration
ratio








II vs I: p = 0.4614, OR = 2.333
III vs I: p = 0.0008, OR = 11.667
IV vs I: p < 0.0001, OR = 301
Table 6. Ratio Zn/Se
Cancer site Quartile Zn/Se concentration
ratio








IV vs I: p = 0.018, OR = 5.000
III vs I: p = 0.148, II vs I: p = 0.534
Table 7. Ratio Fe/Se
Cancer site Quartile Fe/Se concentration
ratio








I vs II: p = 0.372,
I vs III: p = 1.000,
I vs IV: p = 0.549
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